Mosanna Therapeutics Secures $80 Million to Revolutionize Sleep Apnea Treatment with Innovative Nasal Spray Mosanna Therapeutics announces an $80 million funding round to develop an innovative nasal spray for treating obstructive sleep apnea, a condition affecting nearly 1 billion people worldwide.

Mosanna Therapeutics Secures $80 Million to Revolutionize Sleep Apnea Treatment with Innovative Nasal Spray #USA #Redwood_City #Sleep_Apnea #Mosanna_Therapeutics #MOS118